23 research outputs found

    Rarefaction curves.

    No full text
    <p>These curves are representing the numbers of OTUs with respect to the number of pyrosequence reads obtained from each patient at different sampling times and using the two set of primers targeting prokaryotic 16S rDNA (A) and fungal ITS2 (B) loci.</p

    Microbiological data from CF patients included in the study.

    No full text
    a<p>DE, direct examination;</p>b<p>Nested PCR was used to identify <i>Pneumocystis jirovecii</i> colonization <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0036313#pone.0036313-MontesCano1" target="_blank">[26]</a>;</p>c<p>rt-PCR, real-time polymerase chain reaction assay to detect <i>Aspergillus fumigatus</i><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0036313#pone.0036313-Fralle1" target="_blank">[27]</a>;</p>d<p>ND, not done;</p>e<p>PH, Pseudo-hyphae and H, hyphae.</p

    Relation between species richness and clinical status (A) or lung function (B).

    No full text
    <p>Total richness of prokaryotic and fungal communities from each patient-sample was expressed using the Chao1 richness estimator; each spot size is proportional to the corresponding Chao1 value. The clinical status is expressed as S-K score and BMI in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0036313#pone-0036313-g002" target="_blank">Figure 2A</a>, while lung function is expressed as FEV1 and FVC values in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0036313#pone-0036313-g002" target="_blank">Figure 2B</a>. Given to the absence of S-K score value from Patient 2-sample 2 (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0036313#pone-0036313-t001" target="_blank">Table 1</a>), this spot is missing in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0036313#pone-0036313-g002" target="_blank">Figure 2A</a>. Bacterial and fungal Chao1 values corresponding to Patient 1, Patient 2, Patient 3, and Patient 4 are represented in blue-, green-, red- and yellow-edged spots, respectively. Dark and light colour intensity is corresponding to the first and second sampling dates of each patient, respectively. Dark grey and light grey are corresponding to fungal and bacterial Chao1 richness values, respectively.</p

    Clinical data and treatment from CF patients included in the study.

    No full text
    a<p>S-K score, Shwachman-Kulczycki Score;</p>b<p>BMI, body mass index;</p>c<p>FVC, forced vital capacity;</p>d<p>FEV1, forced expiratory volume;</p>e<p>ATB, antibiotic drug;</p>f<p>ATF, antifungal drug;</p>g<p>ITC, itraconazole;</p>h<p>UNK, unknown CFTR mutations associated with an abnormally high sweat chloride test (110 mmol/L).</p

    Two COPD patient Clusters show differentially expressed proteins enriched for distinct biological pathways.

    No full text
    (A) Volcano plot showing differentially expressed proteins between Cluster 1 and Cluster 2. X axis corresponds to log2 (fold change) and Y axis corresponds to -log10 (FDR). Yellow indicates proteins with significant downregulation and blue indicates those with significant upregulation (Fold change >1.5 and FDR versus Cluster 1, regrouped in three core functions defined as “Immunity and defense”, “Cell fate, repair and remodeling”, and “Metabolism and mitochondria”.</p
    corecore